EUVIMEDEUVIMED entdecken
Open Access

Retinoblastoma in Kazakhstan: Incidence Trends and Survival Analysis (2015–2024)

Alua Aubakirova, Akmaral Abikulova, Lyazat Manzhuova, Nazgul Akhtayeva, Aigulsum Izekenova, Gulnara Abdilova, Dinara Berlibek, Farida Sarsekbayeva, Zhanerke Serikova, Neilya Aldasheva

Ocular Oncology and Pathology · 28.04.2026 · 1-9

DOI: 10.1159/000551899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ocular Oncology and Pathology, online erschienen am 28.04.2026. Verfasst von Alua Aubakirova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Kazakh Eye Research Institute, Almaty, Kazakhstan. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Retinoblastoma (Rb) is a rare but aggressive pediatric eye cancer. This study aimed to examine its epidemiological characteristics, diagnostic stages, and survival factors in Kazakhstan, where national-level data have previously been limited.

Methods

A retrospective national registry study was conducted using data from the Scientific Center for Pediatrics and Pediatric Surgery, the country’s referral center for Rb (2015–2024). Incidence was calculated using a birth cohort approach per 100,000 live births. Demographic and clinical characteristics, including diagnostic intervals (lag time 1: symptom onset to diagnosis; lag time 2: diagnosis to treatment initiation), were analyzed. Survival was estimated using Kaplan-Meier methods. Prognostic factors were assessed using univariate and multivariable Cox proportional hazards regression.

Results

A total of 167 cases were recorded. The cumulative birth cohort incidence was 4.18 per 100,000 live births (1:23,915). Median age at diagnosis was 14 months (IQR: 6.5–27.5). Unilateral disease occurred in 78.4% of patients, and 76.9% were diagnosed at advanced stages (D or E). Extraocular involvement was observed in 9.8% of affected eyes. Hereditary Rb accounted for 6% of cases. Median lag time 1 was 60 days (IQR: 30–120), and median lag time 2 was 12 days (IQR: 7–20). Overall mortality was 11.4%, with most deaths occurring within 18 months. Older age at diagnosis (adjusted HR: 1.031; 95% CI: 1.008–1.054; p = 0.009) and longer lag time 2 (adjusted HR: 1.006; 95% CI: 1.004–1.008; p < 0.001) were independently associated with increased mortality.

Conclusion

Rb in Kazakhstan remains characterized by a high proportion of advanced-stage disease and measurable early mortality. Delays in treatment initiation and older age at diagnosis independently predict poorer survival, underscoring the need to strengthen early detection and optimize care pathways.

Schlagwörter

Stichwörter der Autor:innen

EpidemiologyIncidenceKazakhstanPediatric oncologyRetinoblastomaSurvival analysis

Autor:innen und Institutionen

  • Kazakh Eye Research Institute, Almaty, Kazakhstan.
  • Department of Health Policy and Management, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Scientific Center of Pediatrics and Pediatric Surgery, Almaty, Kazakhstan.
  • Department of Biostatistics and Basics of Scientific Research, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Department of Epidemiology with HIV course, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
  • Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.

Zitieren

APA

Aubakirova, A., Abikulova, A., Manzhuova, L., Akhtayeva, N., Izekenova, A., Abdilova, G., Berlibek, D., Sarsekbayeva, F., Serikova, Z., & Aldasheva, N. (2026). Retinoblastoma in Kazakhstan: Incidence Trends and Survival Analysis (2015–2024). Ocular Oncology and Pathology, 1-9. https://doi.org/10.1159/000551899

Vancouver

Aubakirova A, Abikulova A, Manzhuova L, Akhtayeva N, Izekenova A, Abdilova G, et al. Retinoblastoma in Kazakhstan: Incidence Trends and Survival Analysis (2015–2024). Ocular Oncology and Pathology. 2026:1-9. doi:10.1159/000551899

BibTeX
@article{Aubakirova2026,
  author = {Aubakirova, Alua and Abikulova, Akmaral and Manzhuova, Lyazat and Akhtayeva, Nazgul and Izekenova, Aigulsum and Abdilova, Gulnara and Berlibek, Dinara and Sarsekbayeva, Farida and Serikova, Zhanerke and Aldasheva, Neilya},
  title = {Retinoblastoma in Kazakhstan: Incidence Trends and Survival Analysis (2015–2024)},
  journal = {Ocular Oncology and Pathology},
  year = {2026},
  pages = {1--9},
  doi = {10.1159/000551899}
}
Kostenlos starten →